Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
People with celiac disease are twice as likely to be hospitalized if infected with COVID-19, but vaccination can cut that risk in half, a US study has found.
Read Full NewsPhase 2 VALIANT data show the anti-TSLP receptor antibody sharply reduced exacerbations in patients with high eosinophil counts.
Guy Brusselle, MD, PhD, explains why broader cytokine blockade with dupilumab outpaced omalizumab, and why nonremitters in EVEREST still improved.
Exploratory extracellular vesicle biomarkers suggested KP405, a brain-penetrant GLP-1/GIP agonist, engaged insulin signaling and neuroinflammation pathways in a small phase 1 study.
Late-breaking findings from MDS 2026 suggest a gluten-free diet may affect cognitive and quality-of-life measures in Parkinson disease, although no significant changes in motor function were observed.
Seven investigational cerebral palsy therapies—from baby-tooth stem cells to cannabinoids and botulinum toxin—show mixed early results, highlighting key clinical trial milestones ahead.
Benjamin Walter, MD, MBA, discusses how advances in biomarker testing and genetic characterization are informing Parkinson disease care, alongside developments in adaptive deep brain stimulation and efforts to identify disease earlier.
At a NeurologyLive Clinical Forum in Philadelphia, Jessica D. Schulte, MD, PhD, of NYU Grossman School of Medicine, discussed how earlier recognition and systemic therapy options are changing the treatment paradigm for patients with NF1-associated plexiform neurofibromas.
1.
Antibiotic Stewardship: Five Tips to Reduce Resistance
2.
Inner Thoughts of Leonard Bernstein, the "Maestro".
3.
CAR-T for Chronic Lymphocytic Leukemia Receives FDA Approval.
4.
Abnormal Shadow on Chest Radiograph
5.
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.
1.
Survivorship Care Planning Beyond Active Cancer Treatment: Advancing Care Continuity for Cancer Survivors
2.
Hormonal Milestones and Long-Term Cancer Survivorship in Women
3.
Cancer Prevention Through Early Immune Surveillance Enhancement
4.
Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights
5.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge